Literature DB >> 31935177

Alteromonas portus sp. nov., an alginate lyase-excreting marine bacterium.

Huiqin Huang1,2, Kunlian Mo1,2, Shuang Li3,2, Sun Dongmei3, Jun Zhu1,2, Xiaoxiao Zou1,2, Yonghua Hu2,1, Shixiang Bao2,1.   

Abstract

An alginate lyase-excreting bacterium, designated strain HB161718T, was isolated from coastal sand collected from Tanmen Port in Hainan, PR China. Cells were Gram-stain-negative rods and motile with a single polar flagellum. Its major isoprenoid quinone was ubiquinone 8 (Q-8), and its cellular fatty acid profile mainly consisted of C16 : 1 ω7c and/or C16 : 1 ω6c, C18 : 1 ω6c and/or C18 : 1 ω7c, C16 : 0, C17 : 0 10-methyl and C16 : 0 N alcohol. The G+C content of the genomic DNA was 44.1 mol%. 16S rRNA gene sequence analysis suggested that strain HB161718T belonged to the genus Alteromonas, sharing 99.5, 99.4, 99.2, 98.9 and 98.5 % sequence similarities to its closest relatives, Alteromonas macleodii JCM 20772T, Alteromonas gracilis 9a2T, Alteromonas australica H17T, Alteromonas marina SW-47T and Alteromonas mediterranea DET, respectively. The low values of DNA-DNA hybridization and average nucleotide identity showed that it formed a distinct genomic species. The combined phenotypic and molecular features supported the conclusion that strain HB161718T represents a novel species of the genus Alteromonas, for which the name Alteromonas portus sp. nov. is proposed. The type strain is HB161718T (=CGMCC 1.13585T=JCM 32687T).

Entities:  

Keywords:  16S rRNA gene; Alteromonas portus sp. nov.; alginate lyase; polyphasic taxonomy

Mesh:

Substances:

Year:  2020        PMID: 31935177     DOI: 10.1099/ijsem.0.003884

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  1 in total

1.  Expression and Characterization of a Cold-Adapted Alginate Lyase with Exo/Endo-Type Activity from a Novel Marine Bacterium Alteromonas portus HB161718T.

Authors:  Huiqin Huang; Shuang Li; Shixiang Bao; Kunlian Mo; Dongmei Sun; Yonghua Hu
Journal:  Mar Drugs       Date:  2021-03-17       Impact factor: 5.118

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.